Skip to content
Recall Observatory FDA recall evidence

Device product

ELUVIA Drug-Eluting Vascular Stent System - Product Usage: indicated for improving luminal diameter in the treatment of symptomatic de-novo or restenotic lesions in the native superficial femoral artery (SFA) and/or proximal popliteal artery with reference vessel diameters (RVD) ranging from 4.0-6.0 mm and total lesion lengths up to 190 mm.

Z-1621-2021

April 21, 2021

Class II

Product summary

Firm
Boston Scientific Corporation
Event
Event 87839
Status
Terminated
Classification
Class II
Quantity
27 UNITS
Official record key
device-enforcement:Z-1621-2021

Official wording

Reason: One batch of the ELUVIATM Drug Eluting Vascular Stent System incorrect placement of some 6x40mm ELUVIA stents into 6x100mm packaging.

Code information: LOT: 25838357

Distribution pattern: US Nationwide distribution in the states of AL, AR, AZ, CA, DE, HI, IL, KS, KY, MA, MD, NC, NJ, NV, NY, OH, OK, PA,PR, TX, VA,WA,WV.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    One batch of the ELUVIATM Drug Eluting Vascular Stent System incorrect placement of some 6x40mm ELUVIA stents into 6x100mm packaging.